Athanor Capital, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$400,000
-56.0%
18,885
-69.2%
0.01%
-74.3%
Q3 2020$909,000
+154.6%
61,320
+152.9%
0.04%
+94.4%
Q2 2020$357,000
-63.0%
24,242
-30.7%
0.02%
-96.0%
Q1 2018$966,00035,0000.45%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders